Citigroup Inc Biovie Inc. Call Options Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BIVI
# of Institutions
5Shares Held
340KCall Options Held
0Put Options Held
0-
Swisspartners Ltd. Vaduz, N2294KShares$841,8292.92% of portfolio
-
Aj Wealth Strategies, LLC23.5KShares$67,1350.0% of portfolio
-
Black Rock Inc. New York, NY21.2KShares$60,5510.0% of portfolio
-
Provence Wealth Management Group550Shares$1,5730.0% of portfolio
-
Bergan Kdv Wealth Management, LLC100Shares$2860.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $86.3M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...